Regulation of the human Sox9 promoter by the CCAAT-binding factor

Matrix Biology

Volumn 24, Issue 3, 2005, Pages 185-197

  Colter, David C ^a   Piera Velazquez, Sonsoles ^a   Hawkins, David F ^a   Whitecavage, Mary Kate ^a   Jimenez, Sergio A ^a   Stokes, David G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chondrocytes; Sox9; Transcription factors

Indexed keywords

CCAAT BINDING FACTOR; LUCIFERASE; TRANSCRIPTION FACTOR SOX9;

ARTICLE; CHONDROGENESIS; CHROMATIN; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CCAAT-BINDING FACTOR; CELL LINE; GENE DELETION; HIGH MOBILITY GROUP PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

GENETTA;

EID: 19544376643     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2005.04.001     Document Type: Article

References (74)

1. N. Adachi, M. Nomoto, K. Kohno, and H. Koyama Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation Gene 245 2000 49 57
2. H. Akiyama, M.C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6 Genes Dev. 16 2002 2813 2828
3. S. Bagheri-Fam, C. Ferraz, J. Demaille, G. Scherer, and D. Pfeifer Comparative genomics of the Sox9 region in human and Fugu rubripes: conservation of short regulatory sequence elements within large intergenic regions Genomics 78 2001 73 82
4. D.M. Bell, K.K. Leung, S.C. Wheatley, L.J. Ng, S. Zhou, K.W. Ling, M.H. Sham, P. Koopman, P.P. Tam, and K.S. Cheah Sox9 directly regulates the type-II collagen gene Nat. Genet. 16 1997 174 178
5. M. Bellorini, D.K. Lee, J.C. Dantonel, K. Zemzoumi, R.G. Roeder, L. Tora, and R. Mantovani CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues Nucleic Acids Res. 25 1997 2174 2181
6. A. Bhattacharya, J.M. Deng, Z. Zhang, R. Behringer, B. de Crombrugghe, and S.N. Maity The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation Cancer Res. 63 2003 8167 8172
7. W. Bi, J.M. Deng, Z. Zhang, R.R. Behringer, and B. de Crombrugghe Sox9 is required for cartilage formation Nat. Genet. 22 1999 85 89
8. L.C. Bridgewater, V. Lefebvre, and B. de Crombrugghe Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer J. Biol. Chem. 273 1998 14998 15006
9. Z.F. Chang, D.Y. Huang, and S.F. Hu NF-Y-mediated trans-activation of the human thymidine kinase promoter is closely linked to activation of cyclin-dependent kinase J. Cell. Biochem. 75 1999 300 309
10. K.Y. Chen Transcription factors and the down-regulation of G1/S boundary genes in human diploid fibroblasts during senescence Front. Biosci. 2 1997 d417 d426
11. I.B. Coimbra, S.A. Jimenez, D.F. Hawkins, S. Piera-Velazquez, and D.G. Stokes Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes Osteoarthr. Cartil. 12 2004 336 345
12. F. Coustry, Q. Hu, B. de Crombrugghe, and S.N. Maity CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure J. Biol. Chem. 276 2001 40621 40630
13. J.D. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucleic Acids Res. 11 1983 1475 1489
14. Z. Duan, G. Stamatoyannopoulos, and Q. Li Role of NF-Y in in vivo regulation of the gamma-globin gene Mol. Cell. Biol. 21 2001 3083 3095
15. X. Fang, H. Han, G. Stamatoyannopoulos, and Q. Li Developmentally specific role of the CCAAT box in regulation of human gamma-globin gene expression J. Biol. Chem. 279 2004 5444 5449
16. A. Farina, I. Manni, G. Fontemaggi, M. Tiainen, C. Cenciarelli, M. Bellorini, R. Mantovani, A. Sacchi, and G. Piaggio Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex Oncogene 18 1999 2818 2827
17. J.W. Foster Mutations in Sox9 cause both autosomal sex reversal and campomelic dysplasia Acta Paediatr. Jpn. 38 1996 405 411
18. J.W. Foster, M.A. Dominguez-Steglich, S. Guioli, G. Kowk, P.A. Weller, M. Stevanovic, J. Weissenbach, S. Mansour, I.D. Young, and P.N. Goodfellow Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene Nature 372 1994 525 530
19. P. Framson, and P. Bornstein A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene J. Biol. Chem. 268 1993 4989 4996
20. M. Frontini, C. Imbriano, A. diSilvio, B. Bell, A. Bogni, C. Romier, D. Moras, L. Tora, I. Davidson, and R. Mantovani NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s J. Biol. Chem. 277 2002 5841 5848
21. R.R. Genuario, D.E. Kelley, and R.P. Perry Comparative utilization of transcription factor GABP by the promoters of ribosomal protein genes rpL30 and rpL32 Gene Expr. 3 1993 279 288
22. L.F. Good, and K.Y. Chen Cell cycle- and age-dependent transcriptional regulation of human thymidine kinase gene: the role of NF-Y in the CBP/tk binding complex Biol. Signals 5 1996 163 169
23. A. Gurtner, I. Manni, P. Fuschi, R. Mantovani, F. Guadagni, A. Sacchi, and G. Piaggio Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation Mol. Biol. Cell 14 2003 2706 2715
24. C. Healy, D. Uwanogho, and P.T. Sharpe Expression of the chicken Sox9 gene marks the onset of cartilage differentiation Ann. N.Y. Acad Sci. 785 1996 261 262
25. Q. Hu, and S.N. Maity Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes J. Biol. Chem. 275 2000 4435 4444
26. R.J. Isaacs, A.L. Harris, and I.D. Hickson Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells J. Biol. Chem. 271 1996 16741 16747
27. D.B. Jump, A.P. Thelen, and M.K. Mater Functional interaction between sterol regulatory element-binding protein-1c, nuclear factor Y, and 3,5,3′-triiodothyronine nuclear receptors J. Biol. Chem. 276 2001 34419 34427
28. Y. Kanai, and P. Koopman Structural and functional characterization of the mouse Sox9 promoter: implications for campomelic dysplasia Hum. Mol. Genet. 8 1999 691 696
29. G.C. Kennedy, B. Andersen, and J.H. Nilson The human alpha subunit glycoprotein hormone gene utilizes a unique CCAAT binding factor J. Biol. Chem. 265 1990 6279 6285
30. E.C. Kim, J.S. Lau, S. Rawlings, and A.S. Lee Positive and negative regulation of the human thymidine kinase promoter mediated by CCAAT binding transcription factors NF-Y/CBF, dbpA, and CDP/cut Cell Growth Differ. 8 1997 1329 1338
31. C. Kwok, P.A. Weller, S. Guioli, J.W. Foster, S. Mansour, O. Zuffardi, H.H. Punnett, M.A. Dominguez-Steglich, J.D. Brook, and I.D. Young Mutations in Sox9, the gene responsible for Campomelic dysplasia and autosomal sex reversal Am. J. Hum. Genet. 57 1995 1028 1036
32. N. Landsberger, and A.P. Wolffe Role of chromatin and Xenopus laevis heat shock transcription factor in regulation of transcription from the X. laevis hsp70 promoter in vivo Mol. Cell. Biol. 15 1995 6013 6024
33. V. Lefebvre, W. Huang, V.R. Harley, P.N. Goodfellow, and B. de Crombrugghe Sox9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene Mol. Cell. Biol. 17 1997 2336 2346
34. V. Lefebvre, P. Li, and B. de Crombrugghe A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene EMBO J. 17 1998 5718 5733
35. Q. Li, M. Herrler, N. Landsberger, N. Kaludov, V.V. Ogryzko, Y. Nakatani, and A.P. Wolffe Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo EMBO J. 17 1998 6300 6315
36. C. Liberati, A. Ronchi, P. Lievens, S. Ottolenghi, and R. Mantovani NF-Y organizes the gamma-globin CCAAT boxes region J. Biol. Chem. 273 1998 16880 16889
37. H. Madry, and S.B. Trippel Efficient lipid-mediated gene transfer to articular chondrocytes Gene Ther. 7 2000 286 291
38. N. Magan, A.P. Szremska, R.J. Isaacs, and K.M. Stowell Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors Biochem. J. 374 2003 723 729
39. S.N. Maity, and B. de Crombrugghe Role of the CCAAT-binding protein CBF/NF-Y in transcription Trends Biochem. Sci. 23 1998 174 178
40. I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest J. Biol. Chem. 276 2001 5570 5576
41. R. Mantovani The molecular biology of the CCAAT-binding factor NF-Y Gene 239 1999 15 27
42. K. Matuoka, and K. Yu Chen Nuclear factor Y (NF-Y) and cellular senescence Exp. Cell Res. 253 1999 365 371
43. S. Mertin, S.G. McDowall, and V.R. Harley The DNA-binding specificity of Sox9 and other SOX proteins Nucleic Acids Res. 27 1999 1359 1364
44. M. Morishita, T. Kishino, K. Furukawa, A. Yonekura, Y. Miyazaki, T. Kanematsu, S. Yamashita, and T. Tsukazaki A 30-base-pair element in the first intron of Sox9 acts as an enhancer in ATDC5 Biochem. Biophys. Res. Commun. 288 2001 347 355
45. M.C. Motta, G. Caretti, G.F. Badaracco, and R. Mantovani Interactions of the CCAAT-binding trimer NF-Y with nucleosomes J. Biol. Chem. 274 1999 1326 1333
46. K. Mukhopadhyay, V. Lefebvre, G. Zhou, S. Garofalo, J.H. Kimura, and B. de Crombrugghe Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene J. Biol. Chem. 270 1995 27711 27719
47. S. Murakami, M. Kan, W.L. McKeehan, and B. de Crombrugghe Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway Proc. Natl. Acad. Sci. U. S. A. 97 2000 1113 1118
48. S. Murakami, V. Lefebvre, and B. de Crombrugghe Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha J. Biol. Chem. 275 2000 3687 3692
49. L.J. Ng, S. Wheatley, G.E. Muscat, J. Conway-Campbell, J. Bowles, E. Wright, D.M. Bell, P.P. Tam, K.S. Cheah, and P. Koopman Sox9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse Dev. Biol. 183 1997 108 121
50. S. Ninomiya, M. Isomura, K. Narahara, Y. Seino, and Y. Nakamura Isolation of a testis-specific cDNA on chromosome 17q from a region adjacent to the breakpoint of t(12;17) observed in a patient with acampomelic campomelic dysplasia and sex reversal Hum. Mol. Genet. 5 1996 69 72
51. D. Pfeifer, R. Kist, K. Dewar, K. Devon, E.S. Lander, B. Birren, L. Korniszewski, E. Back, and G. Scherer Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to Sox9: evidence for an extended control region Am. J. Hum. Genet. 65 1999 111 124
52. A.M. Reginato, R.V. Iozzo, and S.A. Jimenez Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate Arthritis Rheum. 37 1994 1338 1349
53. A. Ronchi, M. Bellorini, N. Mongelli, and R. Mantovani CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA Nucleic Acids Res. 23 1995 4565 4572
54. A.J. Schafer, M.A. Dominguez-Steglich, S. Guioli, C. Kwok, P.A. Weller, M. Stevanovic, J. Weissenbach, S. Mansour, I.D. Young, and P.N. Goodfellow The role of Sox9 in autosomal sex reversal and campomelic dysplasia Philos. Trans. R. Soc. Lond., B Biol. Sci. 350 1995 271 277 (discussion 277-278)
55. A.J. Schafer, J.W. Foster, C. Kwok, P.A. Weller, S. Guioli, and P.N. Goodfellow Campomelic dysplasia with XY sex reversal: diverse phenotypes resulting from mutations in a single gene Ann. N.Y. Acad. Sci. 785 1996 137 149
56. A. Scholz, M. Truss, and M. Beato Hormone-dependent recruitment of NF-Y to the uteroglobin gene enhancer associated with chromatin remodeling in rabbit endometrial epithelium J. Biol. Chem. 274 1999 4017 4026
57. I. Sekiya, K. Tsuji, P. Koopman, H. Watanabe, Y. Yamada, K. Shinomiya, A. Nifuji, and M. Noda Sox9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line TC6 J. Biol. Chem. 275 2000 10738 10744
58. I. Sekiya, P. Koopman, K. Tsuji, S. Mertin, V. Harley, Y. Yamada, K. Shinomiya, A. Niguji, and M. Noda Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid J. Cell. Biochem. 81 2001 71 78
59. I. Semba, K. Nonaka, I. Takahashi, K. Takahashi, R. Dashner, L. Shum, G.H. Nuckolls, and H.C. Slavkin Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by Sox9 and Msx2 Dev. Dyn. 217 2000 401 414
60. P. Sorensen, and E. Wintersberger Sp1 and NF-Y are necessary and sufficient for growth-dependent regulation of the hamster thymidine kinase promoter J. Biol. Chem. 274 1999 30943 30949
61. D.G. Stokes, and R.P. Perry DNA-binding and chromatin localization properties of CHD1 Mol. Cell. Biol. 15 1995 2745 2753
62. D.G. Stokes, G. Liu, R. Dharmavaram, D. Hawkins, S. Piera-Velazquez, and S.A. Jimenez Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors Biochem. J. 360 2001 461 470
63. D.G. Stokes, G. Liu, I.B. Coimbra, S. Piera-Velazquez, R.M. Crowl, and S.A. Jimenez Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis Arthritis Rheum. 46 2002 404 419
64. A. Subramanian, J. Wang, and G. Gil STAT 5 and NF-Y are involved in expression and growth hormone-mediated sexually dimorphic regulation of cytochrome P450 3A10/lithocholic acid 6beta-hydroxylase Nucleic Acids Res. 26 1998 2173 2178
65. S. Tavella, R. Biticchi, A. Schito, E. Minina, D. Di Martino, A. Pagano, A. Vortkamp, W.A. Horton, R. Cancedda, and S. Garofalo Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression J. Bone Miner. Res. 19 2004 1678 1688
66. H. Uusitalo, H. Salminen, and E. Vuorio Activation of chondrogenesis in response to injury in normal and transgenic mice with cartilage collagen mutations Osteoarthr. Cartil. 9 Suppl. A 2001 S174 S179
67. T. Wagner, J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F.D. Bricarelli, J. Keutel, and E. Hustert Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene Sox9 Cell 79 1994 1111 1120
68. W. Wang, L. Dong, B. Saville, and S. Safe Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions Mol. Endocrinol. 13 1999 1373 1387
69. J. Wirth, T. Wagner, J. Meyer, R.A. Pfeiffer, H.U. Tietze, W. Schempp, and G. Scherer Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from Sox9 Hum. Genet. 97 1996 186 193
70. E. Wright, M.R. Hargrave, J. Christiansen, L. Cooper, J. Kun, T. Evans, U. Gangadharan, A. Greenfield, and P. Koopman The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos Nat. Genet. 9 1995 15 20
71. V.M. Wunderle, R. Critcher, N. Hastie, P.N. Goodfellow, and A. Schedl Deletion of long-range regulatory elements upstream of Sox9 causes campomelic dysplasia Proc. Natl. Acad. Sci. U. S. A. 95 1998 10649 10654
72. B.K. Zehentner, C. Dony, and H. Burtscher The transcription factor Sox9 is involved in BMP-2 signaling J. Bone Miner. Res. 14 1999 1734 1741
73. P. Zhang, S.A. Jimenez, and D.G. Stokes Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by Sox9 J. Biol. Chem. 278 2003 117 123
74. J. Zwicker, C. Gross, F.C. Lucibello, M. Truss, F. Ehlert, K. Engeland, and R. Muller Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1 Nucleic Acids Res. 23 1995 3822 3830